scholarly article | Q13442814 |
P50 | author | Claudiu Popescu | Q56849440 |
P2093 | author name string | Cătălin Codreanu | |
Corina Mogoșan | |||
Marian-Sorin Paveliu | |||
P2860 | cites work | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 |
Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions. | Q33332468 | ||
Willingness to pay for a quality-adjusted life year: in search of a standard | Q33993542 | ||
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. | Q34089998 | ||
Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. | Q34215356 | ||
Treating rheumatoid arthritis to target: recommendations of an international task force | Q34462557 | ||
Cost-of-illness studies: concepts, scopes, and methods | Q34779725 | ||
Rheumatoid arthritis: direct and indirect costs | Q35979186 | ||
A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis | Q36611047 | ||
Comparison of informal care time and costs in different age-related dementias: a review | Q36665371 | ||
Measuring Resource Utilization: A Systematic Review of Validated Self-Reported Questionnaires. | Q37206940 | ||
Contact frequency, travel time, and travel costs for patients with rheumatoid arthritis | Q37626996 | ||
The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates. | Q41132306 | ||
Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists | Q41736186 | ||
Health consumer and patients' organizations in Europe: towards a comparative analysis | Q42384174 | ||
Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. | Q50622974 | ||
Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study. | Q50634044 | ||
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. | Q50672668 | ||
Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. | Q50708359 | ||
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. | Q50732154 | ||
Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania. | Q55100474 | ||
The economic impact of arthritis | Q71010407 | ||
Costs and outcomes in rheumatoid arthritis and osteoarthritis | Q71347965 | ||
The cost of rheumatoid arthritis | Q71408295 | ||
Treatment of rheumatoid arthritis--does it affect society's cost for the disease? | Q71408299 | ||
Economic consequences of the progression of rheumatoid arthritis in Sweden | Q74456128 | ||
A multicenter cost-of-illness study on rheumatoid arthritis in Italy | Q74602775 | ||
Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis | Q79446069 | ||
Therapeutic criteria in rheumatoid arthritis | Q80386526 | ||
Costs of rheumatoid arthritis in Hungary | Q80435945 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | Romania | Q218 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 9343812 | |
P577 | publication date | 2019-06-26 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania | |
P478 | volume | 2019 |
Search more.